Skip to content

Effect of Tongdu Tiaoshen acupunture on hemiplegia and dysphagia after endovascular treatment for the patients with acute cerebral stroke:a retrospective cohort study

Effect of Tongdu Tiaoshen acupunture in the adjuvant treatment of hemiplegia and dysphagia after endovascular treatment for the patients with acute cerebral stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000476
Enrollment
Unknown
Registered
2024-09-25
Start date
2023-12-15
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

None acupuncture group:Sham acupuncture group
Acupuncture group:Tongdu Tiaoshen acupunture

Sponsors

Dongguan TCM Hosptial Affiliated of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: (1) Patients with acute cerebral infarction who meet the diagnostic criteria of Western medicine and have large vessel occlusion confirmed by cranial computed tomography angiography (CTA) magnetic resonance angiography (MRA) or full-brain digital subtraction angiography (DSA) which meets the indications for endovascular treatment [6]; (2) Receiving endovascular therapy including but not limited to arterial thrombolysis thrombosis mechanical thrombectomy balloon plasty stenting and stent implantation and recanalization (mTICI =2b); (3) Age 18~89 years old; (4) The pre-stroke Modified Rankin Score (mRS) score = 1 point; If the symptoms of neurological deficit caused by cerebral infarction appear the National Institutes of Health stroke scale (NIHSS) score United States 5~20 points after the onset of the disease. (5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with major organ failure or severe primary hematopoietic system diseases; (2) Patients with intracranial hemorrhage coagulation dysfunction or bleeding tendency before surgery; (3) Co-existing with severe infection; (4) Pregnant and lactating women and those with a history of allergy to drugs; (5) Patients with contraindications to acupuncture or those with severe primary diseases such as circulatory system respiratory system digestive system urinary system endocrine system and hematopoietic system after stroke and the condition cannot be controlled by conventional medication; Patients with tumors serious infections water-electrolyte and acid-base balance disorders; and other examination abnormalities that are judged by the investigator to be unsuitable for participating in this study. (6) Patients with severe aphasia sleep apnea deafness severe cognitive impairment and inability to communicate effectively; (7) Those who are currently participating in other clinical studies or have participated in other clinical studies for less than 3 months.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health stroke scaleNIHSS;

Secondary

MeasureTime frame
modified Barthel index;Fugl-Meyer assessment scale;Rankin;Kubota drinking water test;Incidence of recurrence risk;

Countries

China

Contacts

Public ContactLi Yue

Dongguan TCM Hosptial Affiliated of Guangzhou University of Chinese Medicine

2281808837@qq.com+86 13060609465

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026